Glenview Trust’s Congress SMid Growth ETF CSMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.8M Buy
1,253,954
+41,789
+3% +$1.4M 0.63% 36
2026
Q1
$37.2M Buy
1,212,165
+216,017
+22% +$7.13M 0.58% 39
2025
Q4
$31.5M Buy
996,148
+58,000
+6% +$1.89M 0.49% 43
2025
Q3
$31.2M Buy
938,148
+36,901
+4% +$1.19M 0.5% 39
2025
Q2
$28.1M Buy
901,247
+141,474
+19% +$4.12M 0.49% 45
2025
Q1
$21M Buy
759,773
+117,561
+18% +$3.49M 0.41% 57
2024
Q4
$19.2M Buy
+642,212
New +$19.6M 0.36% 63

Other funds holding CSMD

Glenview Trust's CSMD Position: Q2 2026 in Review

Glenview Trust increased its Congress SMid Growth ETF (CSMD) stake by 3.4% in Q2 2026, buying an estimated $1.4M and bringing the position to 1,253,954 shares worth $45.8M. The position accounts for 0.63% of the portfolio, ranked #36.

Glenview Trust first reported a position in CSMD in Q4 2024 and has held it in 7 quarters since. 41 funds tracked by Wall St. Rank hold CSMD as of Q2 2026.

  • Glenview Trust held 1,253,954 shares of Congress SMid Growth ETF worth $45.8M as of Q2 2026.
  • Glenview Trust bought 41,789 Congress SMid Growth ETF shares in Q2 2026, an estimated $1.4M.
  • Congress SMid Growth ETF made up 0.63% of Glenview Trust's portfolio in Q2 2026, its #36 holding.
  • Glenview Trust first reported a position in Congress SMid Growth ETF in Q4 2024 and has held it in 7 quarters since.
  • 41 funds tracked by Wall St. Rank held Congress SMid Growth ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.